PlainBillCongress, translated.Legislation. Context. Public interest.

Advancing Hope Act of 2016

Became Public Law No: 114-229.

Official summary

Version 49 · Public Law · Sep 30, 2016

(This measure has not been amended since it was passed by the Senate on September 22, 2016. The summary of that version is repeated here.)

Advancing Hope Act of 2016

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to revise the priority review voucher program for rare pediatric disease medications. (A priority review voucher is a transferable voucher that entitles the holder to have a new drug or biological product application acted upon by the Food and Drug Administration (FDA) within six months.) The program is restricted to treatments for serious diseases and is terminated at the end of 2016.

Showing the opening paragraphs of the official summary.

Read full official summaryShow less

Beginning 90 days after enactment of the bill, a medication sponsor who intends to request a voucher for a rare pediatric disease medication must notify the FDA of that intent upon submission of the application for the medication. The bill applies to applications submitted to the FDA before enactment of the bill that have not been approved. Applications submitted before October 7, 2012, are not eligible for a voucher.

A voucher may not be issued for a rare pediatric disease product if a voucher was already issued for the medication under another program.

(Sec. 3) The Government Accountability Office must study the effectiveness of awarding priority review vouchers as an incentive for the development of medications for rare pediatric diseases that would not otherwise have been developed.

Read the summary on Congress.gov
PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

Who introduced it

Sen. Casey, Robert P., Jr. [D-PA] · D–PA

Committees

  • Energy and Commerce Committee
  • Health, Education, Labor, and Pensions Committee
3 cosponsorship records, including any withdrawals

Actions

A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

  1. Became Public Law No: 114-229.

  2. Became Public Law No: 114-229.

  3. Signed by President.

  4. Signed by President.

  5. Presented to President.

  6. Presented to President.

  7. Motion to reconsider laid on the table Agreed to without objection.

  8. On passage Passed without objection. (text: CR H5945-5946)

  9. Passed/agreed to in House: On passage Passed without objection.(text: CR H5945-5946)

  10. Considered by unanimous consent. (consideration: CR H5945-5946)

  11. Committee on Energy and Commerce discharged.

  12. Committee on Energy and Commerce discharged.

  13. Mr. Walden asked unanimous consent to discharge from committee and consider.

  14. Referred to the House Committee on Energy and Commerce.

  15. Message on Senate action sent to the House.

  16. Received in the House.

  17. Passed Senate with an amendment by Unanimous Consent.

  18. Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.

  19. The committee substitute as amended agreed to by Unanimous Consent.

  20. Measure laid before Senate by unanimous consent. (consideration: CR S6062-6064)

  21. Placed on Senate Legislative Calendar under General Orders. Calendar No. 415.

  22. Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

  23. Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

  24. Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

  25. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  26. Introduced in Senate

Bill text & related measures

Text links open the official source. We currently store references to these documents.

Related bills identified by Congress.gov

Source last updated: Mar 4, 2026. Consult Congress.gov for the current record.

Explore the bill from different angles

Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

Neutral evidence review

Objective

Analyze S.1878 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

View full prompt & sources
Fairness and public impact

Progressive lens

Examine S.1878 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

View full prompt & sources
Institutions and government scope

Conservative lens

Examine S.1878 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

View full prompt & sources
Individual rights and government power

Liberty lens

Examine S.1878 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

View full prompt & sources